Fewer shots for HPV protection? study tests cutting vaccine doses
NCT ID NCT03943875
Summary
This study is testing whether young adults aged 15-26 need two or three doses of the Gardasil 9 HPV vaccine for full protection. Researchers are comparing the standard three-dose schedule against a two-dose schedule with a delayed third dose. They're measuring antibody levels in participants' blood to see if both approaches provide similar immune responses against nine cancer-causing HPV types.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Conditions
Explore the condition pages connected to this study.